Related Experiment Video

Updated: Jun 13, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024)

Mo Wang1,2, Hua-Ying Xiong1,2, Chunhua Zhu3

  • 1Department of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.

Kidney International Reports
|June 12, 2026
PubMed

Insights

New guidelines address Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) in children. These guidelines offer targeted treatment strategies for pediatric CKD-MBD, considering children's unique growth and development needs.

Area of Science:

  • Pediatric Nephrology
  • Mineral and Bone Metabolism
  • Chronic Kidney Disease Complications

Background:

  • Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) universally affects children with CKD, causing metabolic and bone abnormalities.
  • Existing treatment guidelines are primarily for adults, failing to address pediatric-specific growth and developmental needs.
  • Current pediatric CKD-MBD management often relies on adult protocols and medication dosages, lacking tailored approaches.

Purpose of the Study:

  • To establish specific guidelines for the diagnosis and treatment of CKD-MBD in pediatric patients.
  • To provide individualized treatment plans that consider the unique characteristics and developmental stages of children with CKD.
  • To bridge the gap in targeted guidance for managing mineral and bone disorders in children with kidney disease.

Main Methods:

  • Development of guidelines based on the developmental characteristics of children.
  • Integration of expert opinions from pediatric nephrology, nutrition, and medicine specialists.
  • Addressing 15 key clinical questions concerning pediatric CKD-MBD diagnosis and management.

Main Results:

  • Establishment of specific guidelines for pediatric CKD-MBD.
  • Recommendations for individualized treatment plans tailored to children's growth and development.
  • Consideration of age-specific medication ranges and new drug verifications in children.

Conclusions:

  • The new guidelines provide essential, targeted support for managing CKD-MBD in children.
  • Individualized treatment strategies are crucial for optimizing outcomes in pediatric CKD-MBD.
  • These guidelines aim to improve the care and developmental trajectory of children affected by CKD-MBD.

Keywords:
CKD-MBDchildrendiagnosisevaluationguidelinetreatment

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...